Vimarsana
Biggest News Aggregation in the World

Page 12 - Clinical Modification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Modification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Modification Today - Breaking & Trending Today

Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States - Vimarsana News

Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States

Using data from over 16 million people in the United States, Angela Y Chang and colleagues explore how multimorbidity, when considering 63 different conditions, influences health care expenditure.

Source: plos.org
Poor Clinical Outcomes Reported in Patients With COVID-19 and Myocarditis - Vimarsana News

Poor Clinical Outcomes Reported in Patients With COVID-19 and Myocarditis

Patients who are hospitalized with myocarditis secondary to COVID-19 infection are at increased risk for poor clinical outcomes.

Poor Clinical Outcomes Reported in Patients With COVID-19 and Myocarditis - Vimarsana News

Poor Clinical Outcomes Reported in Patients With COVID-19 and Myocarditis

Patients who are hospitalized with myocarditis secondary to COVID-19 infection are at increased risk for poor clinical outcomes.

TCD Screening and Spending Among Children With Sickle Cell Anemia - Vimarsana News

TCD Screening and Spending Among Children With Sickle Cell Anemia

A substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.

Source: ajmc.com
Pharming Group N.V.: Pharming Group reports financial results for full year 2022 - Vimarsana News

Pharming Group N.V.: Pharming Group reports financial results for full year 2022

LEIDEN, Netherlands, March 16, 2023 /PRNewswire/ -- Total revenues increased by 3% to US$205.6 million, in line with single digit growth guidanceOperating profit increased by 34% to US$18.2